click below
click below
Normal Size Small Size show me how
SBGR Development 1
SBGR ALH 175 Development 1 (2012 LS)
| Question | Answer |
|---|---|
| Fertilization | Fusion of two haploid gametes |
| Embryological development | Events that occur during the first two months after fertilization |
| Fetal development | Begins the start of the 9th week and continues until birth |
| Gestation | Time spent in prenatal development |
| Implantation | Begins with the attachment of the blastocyst to the endometrium of the uterus |
| Amniotic cavity | Fluid filled chamber |
| Yolk sac | Primary nutrient source for inner cell mass |
| Amniotic fluid | Surrounds and cushions the developing embryo or fetus |
| Placenta | Primary support mechanism for developing embryo |
| Organogenesis | Process of organ formation |
| Colostrum | Contains antibodies that help an infant ward off infection until the infant’s own immune system becomes fully functional |
| Neonatal period | Time immediately after birth and continuing through the first 28 days |
| Human chorionic gonadotropin (hCG) | Presence in the blood or urine is an indication of pregnancy |
| Relaxin | Peptide hormone that is secreted by the placenta and the corpus luteum |
| Development | The gradual modification of anatomical structures and physiological characteristics from fertilization to maturity |
| Lysozyme | Enzyme with antibiotic properties |
| Amnion | One of the four extra-embryonic membranes; surrounds the developing embryo or fetus |
| Parturition | Expulsion of the fetus and placenta |
| Chorion | Combination of mesoderm and trophoblast that form the beginning of the placenta |
| Blastocyst | Hollow ball of cells |
| Labetalol | |
| Aldomet | |
| Diazepam | |
| Serenace | |
| Cyclizine |